quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:27·91d
SECFiling
Immix Biopharma Inc. logo

SEC Form EFFECT filed by Immix Biopharma Inc.

IMMX· Immix Biopharma Inc.
Health Care
Original source

Companies

  • IMMX
    Immix Biopharma Inc.
    Health Care

Recent analyst ratings

  • Mar 25UpdateMorgan Stanley$20.00
  • Mar 9UpdateCitizens$23.00
  • Feb 9UpdateMizuho$14.00

Related

  • PR14d
    Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
  • SEC17d
    SEC Form DEFA14A filed by Immix Biopharma Inc.
  • SEC17d
    SEC Form DEF 14A filed by Immix Biopharma Inc.
  • SEC24d
    Immix Biopharma Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • SEC27d
    Amendment: SEC Form 10-K/A filed by Immix Biopharma Inc.
  • SEC29d
    SEC Form S-8 filed by Immix Biopharma Inc.
  • SEC29d
    Immix Biopharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
  • SEC29d
    SEC Form 424B5 filed by Immix Biopharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022